Global Psychobiotics Market Growth 2026-2032
The global Psychobiotics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Psychobiotics are a novel class of probiotics that influence brain function and behavior through the gut-brain axis. The gut-brain axis refers to the bidirectional communication between the central nervous system and the gut microbiome, linking cognitive and emotional centers of the brain with intestinal functions. This axis plays a crucial role in influencing mood, cognition, and overall mental health.
United States market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Psychobiotics players cover Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Psychobiotics Industry Forecast? looks at past sales and reviews total world Psychobiotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Psychobiotics sales for 2026 through 2032. With Psychobiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychobiotics industry.
This Insight Report provides a comprehensive analysis of the global Psychobiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychobiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Psychobiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychobiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychobiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychobiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Psychobiotics market?
What factors are driving Psychobiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Psychobiotics market opportunities vary by end market size?
How does Psychobiotics break out by Type, by Application?
Psychobiotics are a novel class of probiotics that influence brain function and behavior through the gut-brain axis. The gut-brain axis refers to the bidirectional communication between the central nervous system and the gut microbiome, linking cognitive and emotional centers of the brain with intestinal functions. This axis plays a crucial role in influencing mood, cognition, and overall mental health.
United States market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Psychobiotics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Psychobiotics players cover Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Psychobiotics Industry Forecast? looks at past sales and reviews total world Psychobiotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Psychobiotics sales for 2026 through 2032. With Psychobiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychobiotics industry.
This Insight Report provides a comprehensive analysis of the global Psychobiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychobiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Psychobiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychobiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychobiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychobiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bifidobacterium Longum
- Lactobacillus Acidophilus
- Lactobacillus Casei
- Other
- Depression
- Stress
- Anxiety
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lallemand Inc
- Novonesis (Novozymes A/S)
- Bened Biomedical
- Sabinsa Corporation
- DuPont Nutrition & Biosciences
- Kerry Group
- Bioprox
- Chr. Hansen
- Mystical Biotech
- Synbiotech
- Glac biotech Co., Ltd.
- Ildong Bioscience Co. Ltd
- JuneYao Health (BioGrowing Co., Ltd)
- Unique Biotech
What is the 10-year outlook for the global Psychobiotics market?
What factors are driving Psychobiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Psychobiotics market opportunities vary by end market size?
How does Psychobiotics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychobiotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Psychobiotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Psychobiotics by Country/Region, 2021, 2025 & 2032
2.2 Psychobiotics Segment by Type
2.2.1 Bifidobacterium Longum
2.2.2 Lactobacillus Acidophilus
2.2.3 Lactobacillus Casei
2.2.4 Other
2.2.5 Psychobiotics Sales by Type
2.2.5.1 Global Psychobiotics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Psychobiotics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Psychobiotics Sale Price by Type (2021-2026)
2.3 Psychobiotics Segment by Application
2.3.1 Depression
2.3.2 Stress
2.3.3 Anxiety
2.3.4 Other
2.3.5 Psychobiotics Sales by Application
2.3.5.1 Global Psychobiotics Sale Market Share by Application (2021-2026)
2.3.5.2 Global Psychobiotics Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Psychobiotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Psychobiotics Breakdown Data by Company
3.1.1 Global Psychobiotics Annual Sales by Company (2021-2026)
3.1.2 Global Psychobiotics Sales Market Share by Company (2021-2026)
3.2 Global Psychobiotics Annual Revenue by Company (2021-2026)
3.2.1 Global Psychobiotics Revenue by Company (2021-2026)
3.2.2 Global Psychobiotics Revenue Market Share by Company (2021-2026)
3.3 Global Psychobiotics Sale Price by Company
3.4 Key Manufacturers Psychobiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psychobiotics Product Location Distribution
3.4.2 Players Psychobiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSYCHOBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Psychobiotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Psychobiotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Psychobiotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Psychobiotics Market Size by Country/Region (2021-2026)
4.2.1 Global Psychobiotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Psychobiotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Psychobiotics Sales Growth
4.4 APAC Psychobiotics Sales Growth
4.5 Europe Psychobiotics Sales Growth
4.6 Middle East & Africa Psychobiotics Sales Growth
5 AMERICAS
5.1 Americas Psychobiotics Sales by Country
5.1.1 Americas Psychobiotics Sales by Country (2021-2026)
5.1.2 Americas Psychobiotics Revenue by Country (2021-2026)
5.2 Americas Psychobiotics Sales by Type (2021-2026)
5.3 Americas Psychobiotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychobiotics Sales by Region
6.1.1 APAC Psychobiotics Sales by Region (2021-2026)
6.1.2 APAC Psychobiotics Revenue by Region (2021-2026)
6.2 APAC Psychobiotics Sales by Type (2021-2026)
6.3 APAC Psychobiotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psychobiotics by Country
7.1.1 Europe Psychobiotics Sales by Country (2021-2026)
7.1.2 Europe Psychobiotics Revenue by Country (2021-2026)
7.2 Europe Psychobiotics Sales by Type (2021-2026)
7.3 Europe Psychobiotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychobiotics by Country
8.1.1 Middle East & Africa Psychobiotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Psychobiotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Psychobiotics Sales by Type (2021-2026)
8.3 Middle East & Africa Psychobiotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psychobiotics
10.3 Manufacturing Process Analysis of Psychobiotics
10.4 Industry Chain Structure of Psychobiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psychobiotics Distributors
11.3 Psychobiotics Customer
12 WORLD FORECAST REVIEW FOR PSYCHOBIOTICS BY GEOGRAPHIC REGION
12.1 Global Psychobiotics Market Size Forecast by Region
12.1.1 Global Psychobiotics Forecast by Region (2027-2032)
12.1.2 Global Psychobiotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Psychobiotics Forecast by Type (2027-2032)
12.7 Global Psychobiotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lallemand Inc
13.1.1 Lallemand Inc Company Information
13.1.2 Lallemand Inc Psychobiotics Product Portfolios and Specifications
13.1.3 Lallemand Inc Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lallemand Inc Main Business Overview
13.1.5 Lallemand Inc Latest Developments
13.2 Novonesis (Novozymes A/S)
13.2.1 Novonesis (Novozymes A/S) Company Information
13.2.2 Novonesis (Novozymes A/S) Psychobiotics Product Portfolios and Specifications
13.2.3 Novonesis (Novozymes A/S) Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novonesis (Novozymes A/S) Main Business Overview
13.2.5 Novonesis (Novozymes A/S) Latest Developments
13.3 Bened Biomedical
13.3.1 Bened Biomedical Company Information
13.3.2 Bened Biomedical Psychobiotics Product Portfolios and Specifications
13.3.3 Bened Biomedical Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bened Biomedical Main Business Overview
13.3.5 Bened Biomedical Latest Developments
13.4 Sabinsa Corporation
13.4.1 Sabinsa Corporation Company Information
13.4.2 Sabinsa Corporation Psychobiotics Product Portfolios and Specifications
13.4.3 Sabinsa Corporation Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sabinsa Corporation Main Business Overview
13.4.5 Sabinsa Corporation Latest Developments
13.5 DuPont Nutrition & Biosciences
13.5.1 DuPont Nutrition & Biosciences Company Information
13.5.2 DuPont Nutrition & Biosciences Psychobiotics Product Portfolios and Specifications
13.5.3 DuPont Nutrition & Biosciences Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 DuPont Nutrition & Biosciences Main Business Overview
13.5.5 DuPont Nutrition & Biosciences Latest Developments
13.6 Kerry Group
13.6.1 Kerry Group Company Information
13.6.2 Kerry Group Psychobiotics Product Portfolios and Specifications
13.6.3 Kerry Group Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kerry Group Main Business Overview
13.6.5 Kerry Group Latest Developments
13.7 Bioprox
13.7.1 Bioprox Company Information
13.7.2 Bioprox Psychobiotics Product Portfolios and Specifications
13.7.3 Bioprox Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bioprox Main Business Overview
13.7.5 Bioprox Latest Developments
13.8 Chr. Hansen
13.8.1 Chr. Hansen Company Information
13.8.2 Chr. Hansen Psychobiotics Product Portfolios and Specifications
13.8.3 Chr. Hansen Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chr. Hansen Main Business Overview
13.8.5 Chr. Hansen Latest Developments
13.9 Mystical Biotech
13.9.1 Mystical Biotech Company Information
13.9.2 Mystical Biotech Psychobiotics Product Portfolios and Specifications
13.9.3 Mystical Biotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mystical Biotech Main Business Overview
13.9.5 Mystical Biotech Latest Developments
13.10 Synbiotech
13.10.1 Synbiotech Company Information
13.10.2 Synbiotech Psychobiotics Product Portfolios and Specifications
13.10.3 Synbiotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Synbiotech Main Business Overview
13.10.5 Synbiotech Latest Developments
13.11 Glac biotech Co., Ltd.
13.11.1 Glac biotech Co., Ltd. Company Information
13.11.2 Glac biotech Co., Ltd. Psychobiotics Product Portfolios and Specifications
13.11.3 Glac biotech Co., Ltd. Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Glac biotech Co., Ltd. Main Business Overview
13.11.5 Glac biotech Co., Ltd. Latest Developments
13.12 Ildong Bioscience Co. Ltd
13.12.1 Ildong Bioscience Co. Ltd Company Information
13.12.2 Ildong Bioscience Co. Ltd Psychobiotics Product Portfolios and Specifications
13.12.3 Ildong Bioscience Co. Ltd Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Ildong Bioscience Co. Ltd Main Business Overview
13.12.5 Ildong Bioscience Co. Ltd Latest Developments
13.13 JuneYao Health (BioGrowing Co., Ltd)
13.13.1 JuneYao Health (BioGrowing Co., Ltd) Company Information
13.13.2 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolios and Specifications
13.13.3 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 JuneYao Health (BioGrowing Co., Ltd) Main Business Overview
13.13.5 JuneYao Health (BioGrowing Co., Ltd) Latest Developments
13.14 Unique Biotech
13.14.1 Unique Biotech Company Information
13.14.2 Unique Biotech Psychobiotics Product Portfolios and Specifications
13.14.3 Unique Biotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Unique Biotech Main Business Overview
13.14.5 Unique Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychobiotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Psychobiotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Psychobiotics by Country/Region, 2021, 2025 & 2032
2.2 Psychobiotics Segment by Type
2.2.1 Bifidobacterium Longum
2.2.2 Lactobacillus Acidophilus
2.2.3 Lactobacillus Casei
2.2.4 Other
2.2.5 Psychobiotics Sales by Type
2.2.5.1 Global Psychobiotics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Psychobiotics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Psychobiotics Sale Price by Type (2021-2026)
2.3 Psychobiotics Segment by Application
2.3.1 Depression
2.3.2 Stress
2.3.3 Anxiety
2.3.4 Other
2.3.5 Psychobiotics Sales by Application
2.3.5.1 Global Psychobiotics Sale Market Share by Application (2021-2026)
2.3.5.2 Global Psychobiotics Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Psychobiotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Psychobiotics Breakdown Data by Company
3.1.1 Global Psychobiotics Annual Sales by Company (2021-2026)
3.1.2 Global Psychobiotics Sales Market Share by Company (2021-2026)
3.2 Global Psychobiotics Annual Revenue by Company (2021-2026)
3.2.1 Global Psychobiotics Revenue by Company (2021-2026)
3.2.2 Global Psychobiotics Revenue Market Share by Company (2021-2026)
3.3 Global Psychobiotics Sale Price by Company
3.4 Key Manufacturers Psychobiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psychobiotics Product Location Distribution
3.4.2 Players Psychobiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSYCHOBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Psychobiotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Psychobiotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Psychobiotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Psychobiotics Market Size by Country/Region (2021-2026)
4.2.1 Global Psychobiotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Psychobiotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Psychobiotics Sales Growth
4.4 APAC Psychobiotics Sales Growth
4.5 Europe Psychobiotics Sales Growth
4.6 Middle East & Africa Psychobiotics Sales Growth
5 AMERICAS
5.1 Americas Psychobiotics Sales by Country
5.1.1 Americas Psychobiotics Sales by Country (2021-2026)
5.1.2 Americas Psychobiotics Revenue by Country (2021-2026)
5.2 Americas Psychobiotics Sales by Type (2021-2026)
5.3 Americas Psychobiotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychobiotics Sales by Region
6.1.1 APAC Psychobiotics Sales by Region (2021-2026)
6.1.2 APAC Psychobiotics Revenue by Region (2021-2026)
6.2 APAC Psychobiotics Sales by Type (2021-2026)
6.3 APAC Psychobiotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psychobiotics by Country
7.1.1 Europe Psychobiotics Sales by Country (2021-2026)
7.1.2 Europe Psychobiotics Revenue by Country (2021-2026)
7.2 Europe Psychobiotics Sales by Type (2021-2026)
7.3 Europe Psychobiotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychobiotics by Country
8.1.1 Middle East & Africa Psychobiotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Psychobiotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Psychobiotics Sales by Type (2021-2026)
8.3 Middle East & Africa Psychobiotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psychobiotics
10.3 Manufacturing Process Analysis of Psychobiotics
10.4 Industry Chain Structure of Psychobiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psychobiotics Distributors
11.3 Psychobiotics Customer
12 WORLD FORECAST REVIEW FOR PSYCHOBIOTICS BY GEOGRAPHIC REGION
12.1 Global Psychobiotics Market Size Forecast by Region
12.1.1 Global Psychobiotics Forecast by Region (2027-2032)
12.1.2 Global Psychobiotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Psychobiotics Forecast by Type (2027-2032)
12.7 Global Psychobiotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lallemand Inc
13.1.1 Lallemand Inc Company Information
13.1.2 Lallemand Inc Psychobiotics Product Portfolios and Specifications
13.1.3 Lallemand Inc Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lallemand Inc Main Business Overview
13.1.5 Lallemand Inc Latest Developments
13.2 Novonesis (Novozymes A/S)
13.2.1 Novonesis (Novozymes A/S) Company Information
13.2.2 Novonesis (Novozymes A/S) Psychobiotics Product Portfolios and Specifications
13.2.3 Novonesis (Novozymes A/S) Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novonesis (Novozymes A/S) Main Business Overview
13.2.5 Novonesis (Novozymes A/S) Latest Developments
13.3 Bened Biomedical
13.3.1 Bened Biomedical Company Information
13.3.2 Bened Biomedical Psychobiotics Product Portfolios and Specifications
13.3.3 Bened Biomedical Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bened Biomedical Main Business Overview
13.3.5 Bened Biomedical Latest Developments
13.4 Sabinsa Corporation
13.4.1 Sabinsa Corporation Company Information
13.4.2 Sabinsa Corporation Psychobiotics Product Portfolios and Specifications
13.4.3 Sabinsa Corporation Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sabinsa Corporation Main Business Overview
13.4.5 Sabinsa Corporation Latest Developments
13.5 DuPont Nutrition & Biosciences
13.5.1 DuPont Nutrition & Biosciences Company Information
13.5.2 DuPont Nutrition & Biosciences Psychobiotics Product Portfolios and Specifications
13.5.3 DuPont Nutrition & Biosciences Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 DuPont Nutrition & Biosciences Main Business Overview
13.5.5 DuPont Nutrition & Biosciences Latest Developments
13.6 Kerry Group
13.6.1 Kerry Group Company Information
13.6.2 Kerry Group Psychobiotics Product Portfolios and Specifications
13.6.3 Kerry Group Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kerry Group Main Business Overview
13.6.5 Kerry Group Latest Developments
13.7 Bioprox
13.7.1 Bioprox Company Information
13.7.2 Bioprox Psychobiotics Product Portfolios and Specifications
13.7.3 Bioprox Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bioprox Main Business Overview
13.7.5 Bioprox Latest Developments
13.8 Chr. Hansen
13.8.1 Chr. Hansen Company Information
13.8.2 Chr. Hansen Psychobiotics Product Portfolios and Specifications
13.8.3 Chr. Hansen Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chr. Hansen Main Business Overview
13.8.5 Chr. Hansen Latest Developments
13.9 Mystical Biotech
13.9.1 Mystical Biotech Company Information
13.9.2 Mystical Biotech Psychobiotics Product Portfolios and Specifications
13.9.3 Mystical Biotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mystical Biotech Main Business Overview
13.9.5 Mystical Biotech Latest Developments
13.10 Synbiotech
13.10.1 Synbiotech Company Information
13.10.2 Synbiotech Psychobiotics Product Portfolios and Specifications
13.10.3 Synbiotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Synbiotech Main Business Overview
13.10.5 Synbiotech Latest Developments
13.11 Glac biotech Co., Ltd.
13.11.1 Glac biotech Co., Ltd. Company Information
13.11.2 Glac biotech Co., Ltd. Psychobiotics Product Portfolios and Specifications
13.11.3 Glac biotech Co., Ltd. Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Glac biotech Co., Ltd. Main Business Overview
13.11.5 Glac biotech Co., Ltd. Latest Developments
13.12 Ildong Bioscience Co. Ltd
13.12.1 Ildong Bioscience Co. Ltd Company Information
13.12.2 Ildong Bioscience Co. Ltd Psychobiotics Product Portfolios and Specifications
13.12.3 Ildong Bioscience Co. Ltd Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Ildong Bioscience Co. Ltd Main Business Overview
13.12.5 Ildong Bioscience Co. Ltd Latest Developments
13.13 JuneYao Health (BioGrowing Co., Ltd)
13.13.1 JuneYao Health (BioGrowing Co., Ltd) Company Information
13.13.2 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolios and Specifications
13.13.3 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 JuneYao Health (BioGrowing Co., Ltd) Main Business Overview
13.13.5 JuneYao Health (BioGrowing Co., Ltd) Latest Developments
13.14 Unique Biotech
13.14.1 Unique Biotech Company Information
13.14.2 Unique Biotech Psychobiotics Product Portfolios and Specifications
13.14.3 Unique Biotech Psychobiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Unique Biotech Main Business Overview
13.14.5 Unique Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psychobiotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Psychobiotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bifidobacterium Longum
Table 4. Major Players of Lactobacillus Acidophilus
Table 5. Major Players of Lactobacillus Casei
Table 6. Major Players of Other
Table 7. Global Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 8. Global Psychobiotics Sales Market Share by Type (2021-2026)
Table 9. Global Psychobiotics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Psychobiotics Revenue Market Share by Type (2021-2026)
Table 11. Global Psychobiotics Sale Price by Type (2021-2026) & (US$/Kg)
Table 12. Global Psychobiotics Sale by Application (2021-2026) & (Ton)
Table 13. Global Psychobiotics Sale Market Share by Application (2021-2026)
Table 14. Global Psychobiotics Revenue by Application (2021-2026) & ($ million)
Table 15. Global Psychobiotics Revenue Market Share by Application (2021-2026)
Table 16. Global Psychobiotics Sale Price by Application (2021-2026) & (US$/Kg)
Table 17. Global Psychobiotics Sales by Company (2021-2026) & (Ton)
Table 18. Global Psychobiotics Sales Market Share by Company (2021-2026)
Table 19. Global Psychobiotics Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Psychobiotics Revenue Market Share by Company (2021-2026)
Table 21. Global Psychobiotics Sale Price by Company (2021-2026) & (US$/Kg)
Table 22. Key Manufacturers Psychobiotics Producing Area Distribution and Sales Area
Table 23. Players Psychobiotics Products Offered
Table 24. Psychobiotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Psychobiotics Sales by Geographic Region (2021-2026) & (Ton)
Table 28. Global Psychobiotics Sales Market Share Geographic Region (2021-2026)
Table 29. Global Psychobiotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Psychobiotics Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Psychobiotics Sales by Country/Region (2021-2026) & (Ton)
Table 32. Global Psychobiotics Sales Market Share by Country/Region (2021-2026)
Table 33. Global Psychobiotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Psychobiotics Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 36. Americas Psychobiotics Sales Market Share by Country (2021-2026)
Table 37. Americas Psychobiotics Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 39. Americas Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 40. APAC Psychobiotics Sales by Region (2021-2026) & (Ton)
Table 41. APAC Psychobiotics Sales Market Share by Region (2021-2026)
Table 42. APAC Psychobiotics Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 44. APAC Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 45. Europe Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 46. Europe Psychobiotics Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 48. Europe Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 49. Middle East & Africa Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 50. Middle East & Africa Psychobiotics Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 52. Middle East & Africa Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 53. Key Market Drivers & Growth Opportunities of Psychobiotics
Table 54. Key Market Challenges & Risks of Psychobiotics
Table 55. Key Industry Trends of Psychobiotics
Table 56. Psychobiotics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Psychobiotics Distributors List
Table 59. Psychobiotics Customer List
Table 60. Global Psychobiotics Sales Forecast by Region (2027-2032) & (Ton)
Table 61. Global Psychobiotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 63. Americas Psychobiotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Psychobiotics Sales Forecast by Region (2027-2032) & (Ton)
Table 65. APAC Psychobiotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 67. Europe Psychobiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 69. Middle East & Africa Psychobiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Psychobiotics Sales Forecast by Type (2027-2032) & (Ton)
Table 71. Global Psychobiotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Psychobiotics Sales Forecast by Application (2027-2032) & (Ton)
Table 73. Global Psychobiotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Lallemand Inc Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 75. Lallemand Inc Psychobiotics Product Portfolios and Specifications
Table 76. Lallemand Inc Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 77. Lallemand Inc Main Business
Table 78. Lallemand Inc Latest Developments
Table 79. Novonesis (Novozymes A/S) Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 80. Novonesis (Novozymes A/S) Psychobiotics Product Portfolios and Specifications
Table 81. Novonesis (Novozymes A/S) Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 82. Novonesis (Novozymes A/S) Main Business
Table 83. Novonesis (Novozymes A/S) Latest Developments
Table 84. Bened Biomedical Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 85. Bened Biomedical Psychobiotics Product Portfolios and Specifications
Table 86. Bened Biomedical Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 87. Bened Biomedical Main Business
Table 88. Bened Biomedical Latest Developments
Table 89. Sabinsa Corporation Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 90. Sabinsa Corporation Psychobiotics Product Portfolios and Specifications
Table 91. Sabinsa Corporation Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. Sabinsa Corporation Main Business
Table 93. Sabinsa Corporation Latest Developments
Table 94. DuPont Nutrition & Biosciences Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 95. DuPont Nutrition & Biosciences Psychobiotics Product Portfolios and Specifications
Table 96. DuPont Nutrition & Biosciences Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. DuPont Nutrition & Biosciences Main Business
Table 98. DuPont Nutrition & Biosciences Latest Developments
Table 99. Kerry Group Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 100. Kerry Group Psychobiotics Product Portfolios and Specifications
Table 101. Kerry Group Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Kerry Group Main Business
Table 103. Kerry Group Latest Developments
Table 104. Bioprox Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 105. Bioprox Psychobiotics Product Portfolios and Specifications
Table 106. Bioprox Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Bioprox Main Business
Table 108. Bioprox Latest Developments
Table 109. Chr. Hansen Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 110. Chr. Hansen Psychobiotics Product Portfolios and Specifications
Table 111. Chr. Hansen Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Chr. Hansen Main Business
Table 113. Chr. Hansen Latest Developments
Table 114. Mystical Biotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 115. Mystical Biotech Psychobiotics Product Portfolios and Specifications
Table 116. Mystical Biotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. Mystical Biotech Main Business
Table 118. Mystical Biotech Latest Developments
Table 119. Synbiotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 120. Synbiotech Psychobiotics Product Portfolios and Specifications
Table 121. Synbiotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 122. Synbiotech Main Business
Table 123. Synbiotech Latest Developments
Table 124. Glac biotech Co., Ltd. Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 125. Glac biotech Co., Ltd. Psychobiotics Product Portfolios and Specifications
Table 126. Glac biotech Co., Ltd. Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 127. Glac biotech Co., Ltd. Main Business
Table 128. Glac biotech Co., Ltd. Latest Developments
Table 129. Ildong Bioscience Co. Ltd Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 130. Ildong Bioscience Co. Ltd Psychobiotics Product Portfolios and Specifications
Table 131. Ildong Bioscience Co. Ltd Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 132. Ildong Bioscience Co. Ltd Main Business
Table 133. Ildong Bioscience Co. Ltd Latest Developments
Table 134. JuneYao Health (BioGrowing Co., Ltd) Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 135. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolios and Specifications
Table 136. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 137. JuneYao Health (BioGrowing Co., Ltd) Main Business
Table 138. JuneYao Health (BioGrowing Co., Ltd) Latest Developments
Table 139. Unique Biotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 140. Unique Biotech Psychobiotics Product Portfolios and Specifications
Table 141. Unique Biotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 142. Unique Biotech Main Business
Table 143. Unique Biotech Latest Developments
Table 1. Psychobiotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Psychobiotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bifidobacterium Longum
Table 4. Major Players of Lactobacillus Acidophilus
Table 5. Major Players of Lactobacillus Casei
Table 6. Major Players of Other
Table 7. Global Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 8. Global Psychobiotics Sales Market Share by Type (2021-2026)
Table 9. Global Psychobiotics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Psychobiotics Revenue Market Share by Type (2021-2026)
Table 11. Global Psychobiotics Sale Price by Type (2021-2026) & (US$/Kg)
Table 12. Global Psychobiotics Sale by Application (2021-2026) & (Ton)
Table 13. Global Psychobiotics Sale Market Share by Application (2021-2026)
Table 14. Global Psychobiotics Revenue by Application (2021-2026) & ($ million)
Table 15. Global Psychobiotics Revenue Market Share by Application (2021-2026)
Table 16. Global Psychobiotics Sale Price by Application (2021-2026) & (US$/Kg)
Table 17. Global Psychobiotics Sales by Company (2021-2026) & (Ton)
Table 18. Global Psychobiotics Sales Market Share by Company (2021-2026)
Table 19. Global Psychobiotics Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Psychobiotics Revenue Market Share by Company (2021-2026)
Table 21. Global Psychobiotics Sale Price by Company (2021-2026) & (US$/Kg)
Table 22. Key Manufacturers Psychobiotics Producing Area Distribution and Sales Area
Table 23. Players Psychobiotics Products Offered
Table 24. Psychobiotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Psychobiotics Sales by Geographic Region (2021-2026) & (Ton)
Table 28. Global Psychobiotics Sales Market Share Geographic Region (2021-2026)
Table 29. Global Psychobiotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Psychobiotics Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Psychobiotics Sales by Country/Region (2021-2026) & (Ton)
Table 32. Global Psychobiotics Sales Market Share by Country/Region (2021-2026)
Table 33. Global Psychobiotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Psychobiotics Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 36. Americas Psychobiotics Sales Market Share by Country (2021-2026)
Table 37. Americas Psychobiotics Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 39. Americas Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 40. APAC Psychobiotics Sales by Region (2021-2026) & (Ton)
Table 41. APAC Psychobiotics Sales Market Share by Region (2021-2026)
Table 42. APAC Psychobiotics Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 44. APAC Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 45. Europe Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 46. Europe Psychobiotics Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 48. Europe Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 49. Middle East & Africa Psychobiotics Sales by Country (2021-2026) & (Ton)
Table 50. Middle East & Africa Psychobiotics Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Psychobiotics Sales by Type (2021-2026) & (Ton)
Table 52. Middle East & Africa Psychobiotics Sales by Application (2021-2026) & (Ton)
Table 53. Key Market Drivers & Growth Opportunities of Psychobiotics
Table 54. Key Market Challenges & Risks of Psychobiotics
Table 55. Key Industry Trends of Psychobiotics
Table 56. Psychobiotics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Psychobiotics Distributors List
Table 59. Psychobiotics Customer List
Table 60. Global Psychobiotics Sales Forecast by Region (2027-2032) & (Ton)
Table 61. Global Psychobiotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 63. Americas Psychobiotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Psychobiotics Sales Forecast by Region (2027-2032) & (Ton)
Table 65. APAC Psychobiotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 67. Europe Psychobiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Psychobiotics Sales Forecast by Country (2027-2032) & (Ton)
Table 69. Middle East & Africa Psychobiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Psychobiotics Sales Forecast by Type (2027-2032) & (Ton)
Table 71. Global Psychobiotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Psychobiotics Sales Forecast by Application (2027-2032) & (Ton)
Table 73. Global Psychobiotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Lallemand Inc Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 75. Lallemand Inc Psychobiotics Product Portfolios and Specifications
Table 76. Lallemand Inc Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 77. Lallemand Inc Main Business
Table 78. Lallemand Inc Latest Developments
Table 79. Novonesis (Novozymes A/S) Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 80. Novonesis (Novozymes A/S) Psychobiotics Product Portfolios and Specifications
Table 81. Novonesis (Novozymes A/S) Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 82. Novonesis (Novozymes A/S) Main Business
Table 83. Novonesis (Novozymes A/S) Latest Developments
Table 84. Bened Biomedical Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 85. Bened Biomedical Psychobiotics Product Portfolios and Specifications
Table 86. Bened Biomedical Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 87. Bened Biomedical Main Business
Table 88. Bened Biomedical Latest Developments
Table 89. Sabinsa Corporation Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 90. Sabinsa Corporation Psychobiotics Product Portfolios and Specifications
Table 91. Sabinsa Corporation Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. Sabinsa Corporation Main Business
Table 93. Sabinsa Corporation Latest Developments
Table 94. DuPont Nutrition & Biosciences Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 95. DuPont Nutrition & Biosciences Psychobiotics Product Portfolios and Specifications
Table 96. DuPont Nutrition & Biosciences Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. DuPont Nutrition & Biosciences Main Business
Table 98. DuPont Nutrition & Biosciences Latest Developments
Table 99. Kerry Group Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 100. Kerry Group Psychobiotics Product Portfolios and Specifications
Table 101. Kerry Group Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Kerry Group Main Business
Table 103. Kerry Group Latest Developments
Table 104. Bioprox Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 105. Bioprox Psychobiotics Product Portfolios and Specifications
Table 106. Bioprox Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Bioprox Main Business
Table 108. Bioprox Latest Developments
Table 109. Chr. Hansen Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 110. Chr. Hansen Psychobiotics Product Portfolios and Specifications
Table 111. Chr. Hansen Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Chr. Hansen Main Business
Table 113. Chr. Hansen Latest Developments
Table 114. Mystical Biotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 115. Mystical Biotech Psychobiotics Product Portfolios and Specifications
Table 116. Mystical Biotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. Mystical Biotech Main Business
Table 118. Mystical Biotech Latest Developments
Table 119. Synbiotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 120. Synbiotech Psychobiotics Product Portfolios and Specifications
Table 121. Synbiotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 122. Synbiotech Main Business
Table 123. Synbiotech Latest Developments
Table 124. Glac biotech Co., Ltd. Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 125. Glac biotech Co., Ltd. Psychobiotics Product Portfolios and Specifications
Table 126. Glac biotech Co., Ltd. Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 127. Glac biotech Co., Ltd. Main Business
Table 128. Glac biotech Co., Ltd. Latest Developments
Table 129. Ildong Bioscience Co. Ltd Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 130. Ildong Bioscience Co. Ltd Psychobiotics Product Portfolios and Specifications
Table 131. Ildong Bioscience Co. Ltd Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 132. Ildong Bioscience Co. Ltd Main Business
Table 133. Ildong Bioscience Co. Ltd Latest Developments
Table 134. JuneYao Health (BioGrowing Co., Ltd) Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 135. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolios and Specifications
Table 136. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 137. JuneYao Health (BioGrowing Co., Ltd) Main Business
Table 138. JuneYao Health (BioGrowing Co., Ltd) Latest Developments
Table 139. Unique Biotech Basic Information, Psychobiotics Manufacturing Base, Sales Area and Its Competitors
Table 140. Unique Biotech Psychobiotics Product Portfolios and Specifications
Table 141. Unique Biotech Psychobiotics Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 142. Unique Biotech Main Business
Table 143. Unique Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Psychobiotics
Figure 2. Psychobiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psychobiotics Sales Growth Rate 2021-2032 (Ton)
Figure 7. Global Psychobiotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Psychobiotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Psychobiotics Sales Market Share by Country/Region (2025)
Figure 10. Psychobiotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bifidobacterium Longum
Figure 12. Product Picture of Lactobacillus Acidophilus
Figure 13. Product Picture of Lactobacillus Casei
Figure 14. Product Picture of Other
Figure 15. Global Psychobiotics Sales Market Share by Type in 2026
Figure 16. Global Psychobiotics Revenue Market Share by Type (2021-2026)
Figure 17. Psychobiotics Consumed in Depression
Figure 18. Global Psychobiotics Market: Depression (2021-2026) & (Ton)
Figure 19. Psychobiotics Consumed in Stress
Figure 20. Global Psychobiotics Market: Stress (2021-2026) & (Ton)
Figure 21. Psychobiotics Consumed in Anxiety
Figure 22. Global Psychobiotics Market: Anxiety (2021-2026) & (Ton)
Figure 23. Psychobiotics Consumed in Other
Figure 24. Global Psychobiotics Market: Other (2021-2026) & (Ton)
Figure 25. Global Psychobiotics Sale Market Share by Application (2025)
Figure 26. Global Psychobiotics Revenue Market Share by Application in 2026
Figure 27. Psychobiotics Sales by Company in 2026 (Ton)
Figure 28. Global Psychobiotics Sales Market Share by Company in 2026
Figure 29. Psychobiotics Revenue by Company in 2026 ($ millions)
Figure 30. Global Psychobiotics Revenue Market Share by Company in 2026
Figure 31. Global Psychobiotics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Psychobiotics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Psychobiotics Sales 2021-2026 (Ton)
Figure 34. Americas Psychobiotics Revenue 2021-2026 ($ millions)
Figure 35. APAC Psychobiotics Sales 2021-2026 (Ton)
Figure 36. APAC Psychobiotics Revenue 2021-2026 ($ millions)
Figure 37. Europe Psychobiotics Sales 2021-2026 (Ton)
Figure 38. Europe Psychobiotics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Psychobiotics Sales 2021-2026 (Ton)
Figure 40. Middle East & Africa Psychobiotics Revenue 2021-2026 ($ millions)
Figure 41. Americas Psychobiotics Sales Market Share by Country in 2026
Figure 42. Americas Psychobiotics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Psychobiotics Sales Market Share by Type (2021-2026)
Figure 44. Americas Psychobiotics Sales Market Share by Application (2021-2026)
Figure 45. United States Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Psychobiotics Sales Market Share by Region in 2026
Figure 50. APAC Psychobiotics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Psychobiotics Sales Market Share by Type (2021-2026)
Figure 52. APAC Psychobiotics Sales Market Share by Application (2021-2026)
Figure 53. China Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Psychobiotics Sales Market Share by Country in 2026
Figure 61. Europe Psychobiotics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Psychobiotics Sales Market Share by Type (2021-2026)
Figure 63. Europe Psychobiotics Sales Market Share by Application (2021-2026)
Figure 64. Germany Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Psychobiotics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Psychobiotics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Psychobiotics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Psychobiotics in 2026
Figure 78. Manufacturing Process Analysis of Psychobiotics
Figure 79. Industry Chain Structure of Psychobiotics
Figure 80. Channels of Distribution
Figure 81. Global Psychobiotics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Psychobiotics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Psychobiotics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Psychobiotics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Psychobiotics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Psychobiotics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Psychobiotics
Figure 2. Psychobiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psychobiotics Sales Growth Rate 2021-2032 (Ton)
Figure 7. Global Psychobiotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Psychobiotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Psychobiotics Sales Market Share by Country/Region (2025)
Figure 10. Psychobiotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bifidobacterium Longum
Figure 12. Product Picture of Lactobacillus Acidophilus
Figure 13. Product Picture of Lactobacillus Casei
Figure 14. Product Picture of Other
Figure 15. Global Psychobiotics Sales Market Share by Type in 2026
Figure 16. Global Psychobiotics Revenue Market Share by Type (2021-2026)
Figure 17. Psychobiotics Consumed in Depression
Figure 18. Global Psychobiotics Market: Depression (2021-2026) & (Ton)
Figure 19. Psychobiotics Consumed in Stress
Figure 20. Global Psychobiotics Market: Stress (2021-2026) & (Ton)
Figure 21. Psychobiotics Consumed in Anxiety
Figure 22. Global Psychobiotics Market: Anxiety (2021-2026) & (Ton)
Figure 23. Psychobiotics Consumed in Other
Figure 24. Global Psychobiotics Market: Other (2021-2026) & (Ton)
Figure 25. Global Psychobiotics Sale Market Share by Application (2025)
Figure 26. Global Psychobiotics Revenue Market Share by Application in 2026
Figure 27. Psychobiotics Sales by Company in 2026 (Ton)
Figure 28. Global Psychobiotics Sales Market Share by Company in 2026
Figure 29. Psychobiotics Revenue by Company in 2026 ($ millions)
Figure 30. Global Psychobiotics Revenue Market Share by Company in 2026
Figure 31. Global Psychobiotics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Psychobiotics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Psychobiotics Sales 2021-2026 (Ton)
Figure 34. Americas Psychobiotics Revenue 2021-2026 ($ millions)
Figure 35. APAC Psychobiotics Sales 2021-2026 (Ton)
Figure 36. APAC Psychobiotics Revenue 2021-2026 ($ millions)
Figure 37. Europe Psychobiotics Sales 2021-2026 (Ton)
Figure 38. Europe Psychobiotics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Psychobiotics Sales 2021-2026 (Ton)
Figure 40. Middle East & Africa Psychobiotics Revenue 2021-2026 ($ millions)
Figure 41. Americas Psychobiotics Sales Market Share by Country in 2026
Figure 42. Americas Psychobiotics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Psychobiotics Sales Market Share by Type (2021-2026)
Figure 44. Americas Psychobiotics Sales Market Share by Application (2021-2026)
Figure 45. United States Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Psychobiotics Sales Market Share by Region in 2026
Figure 50. APAC Psychobiotics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Psychobiotics Sales Market Share by Type (2021-2026)
Figure 52. APAC Psychobiotics Sales Market Share by Application (2021-2026)
Figure 53. China Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Psychobiotics Sales Market Share by Country in 2026
Figure 61. Europe Psychobiotics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Psychobiotics Sales Market Share by Type (2021-2026)
Figure 63. Europe Psychobiotics Sales Market Share by Application (2021-2026)
Figure 64. Germany Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Psychobiotics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Psychobiotics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Psychobiotics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Psychobiotics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Psychobiotics in 2026
Figure 78. Manufacturing Process Analysis of Psychobiotics
Figure 79. Industry Chain Structure of Psychobiotics
Figure 80. Channels of Distribution
Figure 81. Global Psychobiotics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Psychobiotics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Psychobiotics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Psychobiotics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Psychobiotics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Psychobiotics Revenue Market Share Forecast by Application (2027-2032)
